Essentially, this design emulated a randomised controlled trial, in which participants on a background therapy with one of the drug classes of interest (GLP-1 receptor agonists or SGLT-2 inhibitors) are randomised to either continue the background drug or add on the other drug of interest (SGLT-2 inhibitor or GLP-1 receptor agonist, respectively)
Food Chem Toxicol 60:3844 Mantena SK, King AL, Andringa KK, Landar A, Darley-Usmar V et al (2007) Novel interactions of mitochondria and reactive oxygen/nitrogen species in alcohol mediated liver disease
Shafer recommends avoiding new skincare products the day of treatment
A composite analysis of 8 cardiovascular outcomes trials completed in 2021 demonstrated reduced incidence of major cardiovascular events by 14% and cardiovascular death by 13% (NCT01147250, NCT01179048, NCT01720446, NCT01144338, NCT02465515, NCT01394952, NCT02692716, NCT03496298)
BPC-157 is a synthetic pentadecapeptide (15 amino acids) known as Body Protection Compound, based on a partial sequence found in gastric juice
Add 2 mL of bacteriostatic water for a 5 mg/mL concentration